{ "company_number": "10124700", "name": "Xeal Pharma Ltd", "url": "/company/10124700", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2016-04-14", "dissolved_on": null, "sic_codes": [ { "code": "21100", "description": "Manufacture of basic pharmaceutical products", "section": "C", "section_name": "Manufacturing", "url": "/sic/21100" } ], "registered_address": { "id": 294422, "url": "/address/294422", "line1": "UNIT 13 VAUXHALL TRADING ESTATE, DOLLMAN STREET", "line2": "NECHELLS", "post_town": "BIRMINGHAM", "county": "", "country": "ENGLAND", "postcode": "B7 4RA" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/10124700", "previous_names": [ { "name": "Quality Pharma Ltd", "ceased_on": "2017-02-06" } ], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2026-12-31", "last_made_up": "2025-03-31", "category": "TOTAL EXEMPTION FULL", "filings": [ { "url": "/company/10124700/accounts/2025-03-31", "pdf_url": "/company/10124700/accounts/2025-03-31.pdf", "made_up_date": "2025-03-31", "period_start": "2025-03-31", "period_end": "2025-03-31", "entity_name": "Xeal Pharma Ltd", "dormant": false, "average_employees": "49.00", "tangible_fixed_assets": "3280734.00", "debtors": "5346147.00", "cash_bank_in_hand": "1158305.00", "current_assets": "6964452.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "3192564.00", "total_assets_less_current_liabilities": "6473298.00", "net_assets_liabilities": "6273957.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "6273857.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2026.zip" }, { "url": "/company/10124700/accounts/2024-03-31", "pdf_url": "/company/10124700/accounts/2024-03-31.pdf", "made_up_date": "2024-03-31", "period_start": "2024-03-31", "period_end": "2024-03-31", "entity_name": "Xeal Pharma Ltd", "dormant": false, "average_employees": "41.00", "tangible_fixed_assets": "1994285.00", "debtors": "2327791.00", "cash_bank_in_hand": "974226.00", "current_assets": "3622017.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "2398257.00", "total_assets_less_current_liabilities": "4392542.00", "net_assets_liabilities": "4160937.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "4160837.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2025.zip" }, { "url": "/company/10124700/accounts/2023-03-31", "pdf_url": "/company/10124700/accounts/2023-03-31.pdf", "made_up_date": "2023-03-31", "period_start": "2023-03-31", "period_end": "2023-03-31", "entity_name": "Xeal Pharma Ltd", "dormant": false, "average_employees": "36.00", "tangible_fixed_assets": "719332.00", "debtors": "2619592.00", "cash_bank_in_hand": "437802.00", "current_assets": "3304394.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "2430673.00", "total_assets_less_current_liabilities": "3150005.00", "net_assets_liabilities": "2877811.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "2877711.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2023.zip" }, { "url": "/company/10124700/accounts/2022-03-31", "pdf_url": "/company/10124700/accounts/2022-03-31.pdf", "made_up_date": "2022-03-31", "period_start": "2022-03-31", "period_end": "2022-03-31", "entity_name": "Xeal Pharma Ltd", "dormant": false, "average_employees": "22.00", "tangible_fixed_assets": "690906.00", "debtors": "1806916.00", "cash_bank_in_hand": "370895.00", "current_assets": "2354201.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1421091.00", "total_assets_less_current_liabilities": "2111997.00", "net_assets_liabilities": "1661443.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "1661343.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2022.zip" }, { "url": "/company/10124700/accounts/2021-03-31", "pdf_url": "/company/10124700/accounts/2021-03-31.pdf", "made_up_date": "2021-03-31", "period_start": "2021-03-31", "period_end": "2021-03-31", "entity_name": "Xeal Pharma Ltd", "dormant": false, "average_employees": "19.00", "tangible_fixed_assets": "368599.00", "debtors": "652259.00", "cash_bank_in_hand": "341734.00", "current_assets": "1113902.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "553417.00", "total_assets_less_current_liabilities": "922016.00", "net_assets_liabilities": "597519.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "597419.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2021.zip" }, { "url": "/company/10124700/accounts/2020-03-31", "pdf_url": "/company/10124700/accounts/2020-03-31.pdf", "made_up_date": "2020-03-31", "period_start": "2020-03-31", "period_end": "2020-03-31", "entity_name": "Xeal Pharma Ltd", "dormant": false, "average_employees": "9.00", "tangible_fixed_assets": "175170.00", "debtors": "409168.00", "cash_bank_in_hand": "77068.00", "current_assets": "551687.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "157476.00", "total_assets_less_current_liabilities": "332646.00", "net_assets_liabilities": "209439.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "209339.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2020.zip" }, { "url": "/company/10124700/accounts/2019-03-31", "pdf_url": "/company/10124700/accounts/2019-03-31.pdf", "made_up_date": "2019-03-31", "period_start": "2019-03-31", "period_end": "2019-03-31", "entity_name": "Xeal Pharma Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "70922.00", "debtors": "208308.00", "cash_bank_in_hand": "81699.00", "current_assets": "312047.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "46807.00", "total_assets_less_current_liabilities": "117729.00", "net_assets_liabilities": "103715.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "103615.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2019.zip" }, { "url": "/company/10124700/accounts/2018-03-31", "pdf_url": "/company/10124700/accounts/2018-03-31.pdf", "made_up_date": "2018-03-31", "period_start": "2018-03-31", "period_end": "2018-03-31", "entity_name": "Xeal Pharma Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "32614.00", "debtors": "56372.00", "cash_bank_in_hand": "26329.00", "current_assets": "92597.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-36326.00", "total_assets_less_current_liabilities": "-3712.00", "net_assets_liabilities": "-3712.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "-3812.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2018.zip" }, { "url": "/company/10124700/accounts/2017-03-31", "pdf_url": "/company/10124700/accounts/2017-03-31.pdf", "made_up_date": "2017-03-31", "period_start": "2017-03-31", "period_end": "2017-03-31", "entity_name": "Xeal Pharma Limited", "dormant": false, "average_employees": "4.00", "tangible_fixed_assets": "32858.00", "debtors": "9951.00", "cash_bank_in_hand": "703.00", "current_assets": "15034.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-71778.00", "total_assets_less_current_liabilities": "-38920.00", "net_assets_liabilities": "-38920.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "-39020.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2017.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/10124700/filing-history" }, "confirmation_statement": { "next_due": "2027-04-27", "last_made_up": "2026-04-13" }, "officers": [ { "name": "JAFAR, Husam Amer Hisham", "person_url": "/person/6094205", "role": "director", "appointed_on": "2018-12-12", "resigned_on": "2026-07-17", "nationality": "British", "occupation": "", "source": "stream", "retrieved_at": "2026-07-17T13:12:03+00:00" } ], "psc": [ { "name": "Mr Azhar-Zafeer Chughtai", "kind": "individual-person-with-significant-control", "person_url": "/person/577856", "controlling_company_url": null, "natures_of_control": [ "significant-influence-or-control" ], "notified_on": "2016-04-14", "ceased_on": null, "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Mr Husam Amer Hisham Jafar", "kind": "individual-person-with-significant-control", "person_url": "/person/1941827", "controlling_company_url": null, "natures_of_control": [ "significant-influence-or-control" ], "notified_on": "2016-04-14", "ceased_on": null, "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Mr Haidar Abdullah Mohammed Al-Bukhari", "kind": "individual-person-with-significant-control", "person_url": "/person/1806325", "controlling_company_url": null, "natures_of_control": [ "significant-influence-or-control" ], "notified_on": "2016-04-14", "ceased_on": null, "nationality": "British", "country_of_residence": "United Kingdom", "source": "snapshot" }, { "name": "Mr Ibraar Mahmood Sultan", "kind": "individual-person-with-significant-control", "person_url": "/person/1983362", "controlling_company_url": null, "natures_of_control": [ "significant-influence-or-control" ], "notified_on": "2016-04-14", "ceased_on": null, "nationality": "British", "country_of_residence": "England", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-29T21:09:53.382073+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }